Your page scores 54 out of 100 for sameness against the 4 competitors you named.

Claims only you make, that buyers weigh, and that competitors can’t easily copy.

Territory you spend prominent space on that the set also occupies. Not every line is one to delete — the question is whether it has earned the space, or whether something only you can say should be there instead.

• Commodity · 100%Table stakesHero

  quantified prescription/engagement lift results

  • “The HCP engagement platform that drives verifiable script lift”
  • “Our clients achieve 3x script lift on average”

  You say this 2 different ways.

  ODAIA, Doceree, DeepIntent and PulsePoint all cover this territory. Buyers may need to hear it, but in your hero it spends the first impression on shared ground.

  This is grouped wrong
  They say

  • ODAIA“Our AI helps uncover missed Rx opportunity”
  • Doceree“Real Doceree script-lift study: +25% TRx lift”
  • DeepIntent“Drive better outcomes by optimizing for pharma KPIs like audience quality (AQ) and script lift”
  • PulsePoint“97.4% Increase in clicks”
• Commodity · 100%Table stakesHero

  ties media to NPI-level prescription outcomes

  • “Live dashboards prove impact instantly, tying each touchpoint to NPI-level lift to defend every dollar spent”
  • “Connect the dots from exposure to lift now, not in 6 months”

  You say this 2 different ways.

  Common ground with ODAIA, Doceree, DeepIntent and PulsePoint. Say it if buyers need it — lower on the page, where it is not the thing they read first.

  This is grouped wrong
  They say

  • ODAIA“connect every touchpoint to real Rx outcomes”
  • Doceree“A closed loop that ends where revenue actually starts: the prescription filled, measured against a matched control”
  • DeepIntent“Track your campaigns within a streamlined dashboard where clinical data is refreshed daily”
  • PulsePoint“Physician-Level Data Reporting”
• Commodity · 75%Table stakesHero

  actionable insights rather than raw data

  • “No disjointed systems, data lags, or fuzzy attribution”

  ODAIA, DeepIntent and PulsePoint make the same claim (75% of the set). It cannot set you apart, so it should not carry the hero. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

  This is grouped wrong
  They say

  • ODAIA“A clear and comprehensive understanding of HCPs and their patient decisions”
  • DeepIntent“Monitor and improve your performance based on real-time data signals”
  • PulsePoint“You get a clear view into every HCP's clinical and digital journey”
• Commodity · 75%Table stakesHero

  omnichannel coordination of HCP and DTC engagement

  • “Our real-time orchestration engine automatically coordinates digital and field to eliminate guesswork”
  • “We create smarter, faster approaches across functions that deliver wins, increase revenue, and drive measurable HCP and DTC engagement throughout the product…”
  • “Reach HCPs on the channels they already use”

  You say this 3 different ways.

  A buyer comparing tabs sees this on ODAIA, DeepIntent and PulsePoint too (75% of the set). Yours earns nothing by repeating it up top; it can live lower down.

  This is grouped wrong
  They say

  • ODAIA“coordinate omnichannel execution”
  • DeepIntent“Connect with HCP and DTC audiences wherever they're engaging with digital content”
  • PulsePoint“Coordinated Campaigns”
• Contested · 50%SharpenHero

  fast time to value and deployment

  • “Marketers can engage HCPs within 48 hours of a clinical signal on your optimal channel mix”
  • “A fully deployed system activated in 6-8 weeks”
  • “From signal to deployment in 24 hours”

  You say this 3 different ways.

  ODAIA and DeepIntent are on this territory too (50% of the set). It narrows the field without winning it — make it specific enough that it cannot be said of them. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

  This is grouped wrong
  They say

  • ODAIA“I only spend five minutes on ODAIA before I connect with them”
  • DeepIntent“Fast, pharma-specific measurement”
• Commodity · 75%Table stakesSection

  proprietary data assets and identity graph scale

  • “We know what 7M HCPs prefer today (channel, message, format, vendor)”

  Doceree, DeepIntent and PulsePoint got here first as far as a buyer can tell. Keep the fact for readers who need it; move the position to a claim only your page can make. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

  This is grouped wrong
  They say

  • Doceree“Built on the industry's largest real-time clinical signal network”
  • DeepIntent“98% of prescribing HCP universe reached”
  • PulsePoint“Powering The World's Largest Healthcare Marketing Ecosystem”
• Commodity · 75%Table stakesSection

  purpose-built for pharma with industry expertise

  • “Our leaders truly understand your needs–because they've been in your shoes”
  • “Pharma marketing doesn't need another platform—it needs a force”

  You say this 2 different ways.

  Shared with ODAIA, DeepIntent and PulsePoint, 75% of the set. True of you, true of them — which is exactly why it will not decide anything. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

  This is grouped wrong
  They say

  • ODAIA“The Commercial Intelligence Platform Built for Pharma”
  • DeepIntent“The platform designed with healthcare marketers in mind”
  • PulsePoint“Innovative advertising technology to support the healthcare marketer's unique needs”
• Commodity · 75%Table stakesSection

  quantified revenue/ROI and cost-efficiency results

  • “20% Average media savings (with higher ROI)”

  Nothing wrong with the claim; ODAIA, Doceree and PulsePoint just make it as well. Treat it as the price of entry and spend the prominent space elsewhere. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

  This is grouped wrong
  They say

  • ODAIA“$53B Revenue supported”
  • Doceree“Diabetes case study: 4.7x co-pay utilization”
  • PulsePoint“6.48 ROAS for hcp media”
• Commodity · 75%Table stakesSection

  unifies data into one platform/interface

  • “We unite deep HCP intelligence, dynamic execution across all channels, and live NPI-level reporting”

  ODAIA, Doceree and DeepIntent make the same claim (75% of the set). It cannot set you apart, so it should not carry the section.

  This is grouped wrong
  They say

  • ODAIA“ODAIA simplifies my pre-call planning by consolidating multiple data sources in one”
  • Doceree“Doceree's infrastructure unifies the entire healthcare journey - from physician awareness to prescription and patient fill to refill”
  • DeepIntent“It only takes one platform to design, launch, and optimize an effective pharma campaign”
• Contested · 25%SharpenSection

  reduces wasted media spend / lowers cost

  • “Optichannel focuses your resources, eliminating wasted spend”

  Shared with Doceree. Sharpen it to the thing only you do here, or it reads as a claim any of you could make. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

  This is grouped wrong
  They say

  • Doceree“20 years of legacy media optimized for reach & impressions, never connected to the script that gets filled”
• Contested · 25%SharpenSection

  scale of deployment and usage

  • “Deploy across 75K+ touchpoints to seize every opportunity”

  Contested ground: ODAIA claim it as well. The version that wins names a mechanism, a number or a scope that theirs cannot match. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

  This is grouped wrong
  They say

  • ODAIA“40+ Brands onboarded”
• Contested · 25%SharpenSection

  unique/only-vendor category positioning

  • “We don't pitch your rivals; we only support one product per indication”

  Section-level, and shared: Doceree is on this territory too (25% of the set). It narrows the field without winning it — make it specific enough that it cannot be said of them. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.

  This is grouped wrong
  They say

  • Doceree“Doceree is the only healthcare marketing platform that can measure and adapt to the actual clinical intent of both physicians and patients”

Sameness measures how much your claims overlap with the sites compared. It does not measure message quality or whether buyers prefer you.

AI-analyzed: an AI read each page on its own and grouped the claims that say the same thing. No score here was written by a model — every number is computed from those groupings in our own code, with the weights below.

Trusted by